Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Financière de Tubize SA: Half-year Financial Report 2018


Posted on: 26 Jul 18

Press release
26 July 2018
Embargo till 08:00h CET

FINANCIERE DE TUBIZE SA

Allée de la Recherche 60, 1070 Brussels

Contact: Anne Sophie Pijcke, day-to-day management, aspijcke@icloud.com

2018 half-year financial report

Regulated information
26 July 2018

The board of directors of Financière de Tubize has issued the 2018 half-year financial report.  This report is available on the website www.financiere-tubize.be

  • Dividend received from UCB: € 80.3 million
  • Profit for the period when applying the Belgian accounting framework: € 78.2 million
  • Profit for the period when applying the international standard IAS 34: € 197.5 million
  • Participating interest in UCB unchanged at 35.00%
  • Decreasing bank debt from € 192 million at 31 December 2017 to € 139 million at 30 June 2018.
GlobeNewswire
globenewswire.com

Last updated on: 26/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.